Sign in

CIK 0001099800

  • Large accelerated filer

Edwards Lifesciences Corp

Sign in to watch
Ticker
EW
Exchange
NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364316614
Phone
+1 949-250-2500
Business address
ONE EDWARDS WAY, IRVINE, CA, 92614
Former names
CVG CONTROLLED INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$10,886,105
in 9 filings, $7.6M under 10b5-1 plans

Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-07 MUSSALLEM MICHAEL A Director Sale 10b5-1 −29,050 $79.86 $2.3M 54,251.82
2023-08-07 MUSSALLEM MICHAEL A Director Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 −29,350 264,150
2023-07-31 Zovighian Bernard J CEO Other acquisition +2,558.62 $83.54 $214K 47,111.49
2023-07-31 Ullem Scott B. CVP, Chief Financial Officer Exercise or conversion 10b5-1 +7,255 $36.75 $267K 26,503
2023-07-31 Ullem Scott B. CVP, Chief Financial Officer Sale 10b5-1 −7,255 $84.35 $612K 19,248
2023-07-31 Ullem Scott B. CVP, Chief Financial Officer Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 −7,255 65,290
2023-07-14 BOBO DONALD E JR CVP,Strategy/Corp Development Exercise or conversion 10b5-1 +3,500 $36.75 $129K 43,002.69
2023-07-14 BOBO DONALD E JR CVP,Strategy/Corp Development Sale 10b5-1 −3,500 $92.94 $325K 39,502.69
2023-07-14 BOBO DONALD E JR CVP,Strategy/Corp Development Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 −3,500 76,000
2023-07-14 Wood Larry L Global President TAVR & Surg Exercise or conversion 10b5-1 +8,660 $45.28 $392K 222,453.71
2023-07-14 Wood Larry L Global President TAVR & Surg Sale 10b5-1 −8,660 $92.94 $805K 213,793.71
2023-07-14 Wood Larry L Global President TAVR & Surg Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 −8,660 41,059
2023-07-10 Szyman Catherine M. CVP, Critical Care Exercise or conversion 10b5-1 +5,000 $36.75 $184K 39,813.57
2023-07-10 Szyman Catherine M. CVP, Critical Care Sale 10b5-1 −5,000 $90.52 $453K 34,813.57
2023-07-10 Szyman Catherine M. CVP, Critical Care Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 −5,000 62,000
2023-07-07 Szyman Catherine M. CVP, Critical Care Shares withheld for taxes 10b5-1 −252 $90.46 $23K 34,813.57
2023-07-07 Lemercier Jean-Luc M CVP, EMEACLA and JAPAC Shares withheld for taxes −81 $90.46 $7K 173,583.78
2023-07-05 MUSSALLEM MICHAEL A Director Exercise or conversion 10b5-1 +29,350 $36.75 $1.1M 83,601.82
2023-07-05 MUSSALLEM MICHAEL A Director Sale 10b5-1 −7,622 $91.22 $695K 75,979.82
2023-07-05 MUSSALLEM MICHAEL A Director Sale 10b5-1 −21,728 $90.63 $2.0M 54,251.82

Page 36 of 43 · 841 trades